telbivudine has been researched along with Acute Kidney Injury in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bair, MJ; Cai, ZS; Chang, CW; Chen, CJ; Chen, MJ; Lin, CC; Lin, YS; Yu, HC | 1 |
| Bedir, A; Celikbilek, M; Das, YK; Kader, C; Karaca, E; Ozaras, R; Sunbul, M; Yarim, M | 1 |
| Chang, ML; Chen, YC; Chien, RN; Hsu, CW; Lin, CL; Yeh, C; Yeh, CT | 1 |
| Dang, S; Gao, N; Jia, X; Zhang, X | 1 |
1 trial(s) available for telbivudine and Acute Kidney Injury
| Article | Year |
|---|---|
Significant renoprotective effect of telbivudine during preemptive antiviral therapy in advanced liver cancer patients receiving cisplatin-based chemotherapy: a case-control study.
Topics: Acute Kidney Injury; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carcinoma, Hepatocellular; Cisplatin; Female; Fluorouracil; Hepatitis B, Chronic; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Mitomycin; Protective Agents; Telbivudine; Thymidine; Treatment Outcome | 2014 |
3 other study(ies) available for telbivudine and Acute Kidney Injury
| Article | Year |
|---|---|
Efficacy of telbivudine and entecavir against virus reactivation in HBeAg-patients undergoing chemotherapy.
Topics: Acute Kidney Injury; Adult; Aged; Antineoplastic Agents; Antiviral Agents; Female; Glomerular Filtration Rate; Guanine; Hepatitis B e Antigens; Humans; Kidney Function Tests; Male; Middle Aged; Neoplasms; Retrospective Studies; Telbivudine | 2020 |
Telbivudine attenuates gentamicin-induced kidney injury in rats.
Topics: Acute Kidney Injury; Animals; Cystatin C; Gentamicins; Glomerular Filtration Rate; Hepatitis B, Chronic; Kidney; Lamivudine; Male; Pilot Projects; Protein Synthesis Inhibitors; Rats; Rats, Wistar; Telbivudine; Thymidine | 2017 |
Rhabdomyolysis in a 48-year-old man with hepatitis B-induced cirrhosis.
Topics: Acute Kidney Injury; Antiviral Agents; Fatal Outcome; Fibrosis; Hepatitis B; Humans; Male; Middle Aged; Muscular Diseases; Nucleosides; Pyrimidinones; Rhabdomyolysis; Telbivudine; Thymidine; Treatment Outcome | 2011 |